SPRINGFIELD - The Illinois Office of the Attorney General (OAG) reached a settlement on behalf of the Illinois Department of ...

Illinois officials indicated that the settlement is about a larger issue than just a contract dispute with one PBM.

Illinois secured a $45 million settlement with CVS Caremark over pharmacy benefit management transparency issues.

Illinois and CVS Caremark reach a $45 million settlement over pharmaceutical rebates, lowering the liability to taxpayers for ...

CVS Caremark to list Wegovy as preferred GLP-1 drug on top formularies starting July 1, 2025. Novo Nordisk plans continued collaboration with CVS to widen Wegovy access. Get Matt Maley’s top ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients. By Rebecca Robbins ...

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template formularies, Novo said Thursday. CVS Caremark, which forms the ...

In July, CVS Caremark agreed to pay $45 million to Illinois to settle allegations it wrongfully pocketed rebates.